“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Related posts:
Yemen: a catastrophe that shames Britain
Welsh city refuses man's £7.4 million offer to dig for lost Bitcoin
D.C. house inspires 168 bids in red-hot real estate market
Kentucky Gains Federal Permit For Its Hemp Seeds
U.S. Homeownership Rate Falls to 20-Year Low
Will Migrant Workers Drive Bitcoin's Mundane Future?
Japan ‘takes issue with Google maps’ over disputed islands
Bloomberg: The Death of Cash
Scotland Yard stole dead children’s identities
Supreme court cellphone case puts free speech – not just privacy – at risk
Bitcoin Pursues the Mainstream
NATO: No Sign Russian Troops Are Pulling Back From Ukraine
Barack Obama’s ‘extreme’ anti-terror tactics face liberal backlash
Blind Mice Given Sight After Device Cracks Retinal Code
Family of Woman Who Led Cops on Capitol Car Chase Suing Police